Interestingly, oroxylin A was reported to activate UPR in HepG2 cancer cells by the PERK/eIF2α/ATF4 pathway, but excessive activation of this pathway resulted in the activation of CHOP and induced cell death [19]. The gene discussed is EIF2AK3; the disease is cancer.